| Best for | A company with its own quality function that brings the platform into its own submissions, with commercial use permitted. | Multi-site feasibility, pivotal and investigator-initiated studies, the data and system side of a regulatory submission, and commercial deployments with no clinical data. | Cleared or approved devices with live patient data: post-market and post-approval studies including Section 522 surveillance, registries and real-world evidence, new-indication studies, complex pivotals at operational scale, and commercial operations. |
|---|
| Single sign-on | For your own organization and at tenant level, so each of your tenants signs its users in through its own identity provider | For your own organization | For your own organization and at tenant level, so each of your tenants signs its users in through its own identity provider |
|---|
| Devices in the field | Fleet management | Fleet management and secure over-the-air updates | Fleet management and secure over-the-air updates |
|---|
| Threshold alerts | Yes | Yes | Yes |
|---|
| Audit log | Yes | Yes | Yes |
|---|
| AI SaMD algorithm deployment | Deployment you control | Deployment you control | Deployment you control |
|---|
| Support | Dedicated support and SLA | Dedicated support and SLA | Dedicated support and SLA |
|---|
| Agreements | Master Services Agreement, template quality agreement, BAA, DPA where needed | Master Services Agreement, quality agreement, BAA, DPA where needed | Master Services Agreement, quality agreement, BAA, DPA where needed |
|---|